News

We are thrilled to share that the Global Pharmacovigilance Professional Certification program has been officially approved by the ISoP Executive Committee and the General Assembly during last week’s meeting in Montreal. On 11 October 2024, we launched the pilot phase to test all aspects before the full certification process for the first roles begins.

We have been working tirelessly on the certification for quite some time and would like to present you how far we got. While the implementation has been slower than expected, we focus on the quality of the certification and collaborate with several pharmacovigilance expert groups both on local and global scale.

The Institute of Pharmacovigilance does not only certify individuals based on their knowledge, skills, and attitudes in pharmacovigilance, but also based on their knowledge of local applicable regulation. For this purpose, we are developing an extensive platform called PVReg and we would like to present you the latest news.

Artificial Intelligence and Machine Learning are the most recognized technologies right now, and they are taking pharmacovigilance to the next level.  
We bring you a recently published article written by a team of PV professionals, including our CEO, Jan Petracek:
The Use of Artificial Intelligence in Pharmacovigilance: A Systematic Review of the Literature

After working in the pharma industry sector for more than two decades based in Asia, Jean-Christophe Delumeau (MD, PhD, FISoP), joined our Institute as a Board Director. 

It is our pleasure to welcome Jean-Christophe to our team and share details on his background and engagement within the Institute.

Have you ever asked yourself this question? Let us present you a few reasons why getting certified should be on your to-do list! 

ISoP through its mission plays a pivotal role in pharmacovigilance worldwide. The quality of pharmacovigilance work depends primarily on the competence of people performing pharmacovigilance tasks.

Here, at the Institute, one of our aims is to keep you updated, as we want you to be a part of our journey. 
To know who we are, what are our beliefs and what we are working towards.
And there is no better person for this task than our Director, Jan Petracek.

The whole team worked effortlessly to reach this important milestone. It is another stepping stone towards accomplishing our mission - improving the competency of pharmacovigilance professionals, enhancing performance and recognition of the whole pharmacovigilance discipline.   

The team of the Institute is growing and the accomplishment of our mission to create Global Pharmacovigilance Professional Certification is on the horizon.
We believe that the knowledge and support of the Director of GPPC, Mr. Tomas Pikola, MBA, will help us to reach our goal.  

Tomas is an experienced Training and Development Lead with a demonstrated history of working in the information technology and services industry.
And this is a perfect opportunity to introduce Tomas and welcome him to the team. 

Dr Jan Petracek's full video presentation 'Risk of Automation: Lessons from Aviation for Pharmacovigilance' from the latest 2021 ISOP Seminar, Intelligent Automation in Pharmacovigilance, based in Boston, USA.

The staff members of the Institute of Pharmacovigilance wish you a happy festive season.

Looking forward to our cooperation in 2022!

It is our pleasure to invite you to yet another ISoP Seminar, via Zoom, 6-7 December 2021.

The great tradition of ISoP is to limit commercial bias as much as possible, and focus on science and methodology behind the marketing buzz words. This year, you can expect another panel of senior speakers from innovative biotech and pharma companies along with members of different regulatory authorities.

As one VP level participant said, this is "easily the best event in the field you can attend worldwide, by far!". 

On Tuesday 9th November, the annual ISoP General assembly took place during the 20th ISoP Annual Meeting hosted from Oman.
Among discussed topics, there was one especially close to our hearts.

We introduced our Regulatory Intelligence Manager, Jana Freeman previously, in the meet the team section. This time we sat down and asked 4 questions to see what her work is all about.

Annual Pharmacovigilance Seminar was held last week on October 19.

International Society of Pharmacovigilance in cooperation with World Health Organization, is presenting Periodic Benefit - Risk Evaluation Report (PBRER) Making and Assessment Course. 

We would like to share our latest news on what we have been working on. ISoP Special Interest Group on Pharmacovigilance Professional Qualification Framework, in collaboration with the Institute of Pharmacovigilance, has developed a guideline as the first step while developing the Global Pharmacovigilance Professional Certification (GPPC) program.

We are happy to announce that the director of the Institute of Pharmacovigilance, Dr. Jan Petracek, will be leading the discussions and training courses on the 5th Module – Signal Management for this year’s DIA/MEB Excellence in Pharmacovigilance virtual course. This is the most anticipated Pharmacovigilance course of the year!

We proudly present another member of the Institute of Pharmacovigilance, Milena Buzkova, MSc who is a member of the IPV Management Board.
Milena has a wide range of experience in management, and in organizing international agreements, as well as in administration. Thanks to her skills and nearly 15 years of experience in the pharmacovigilance industry, Milena is a valuable member of the Board.